The FDA Commissioner Is Missing the Point of Advisory Committees

(MedPage Today) — The recent controversies about the safety of antidepressants during pregnancy and hormone therapy for menopause were heightened by how decisions are being made. Earlier this month, HHS officials announced that boxed warnings…